Free tool
Cell therapy stocks
We cover 2 companies grouped under the Cell therapy theme. The median market value in the group is $203.60M. Across the group, the median move over the past trading day is +1.55%. Price change over the past year runs from −28.9% to −28.2% across the middle 80 percent of the group, with a median of −28.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 86 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 219A.T | HEARTSEED INC | $350.89M | Small cap | −28.06% |
| 4584.T | Kidswell Bio Corporation | $56.31M | Micro cap | −29.02% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.